Incidence and mortality of malignant tumors and their impacts on life expectancy in Yixing ， Jiangsu， 2019
10.19428/j.cnki.sjpm.2021.20433
- VernacularTitle:2019年江苏宜兴市恶性肿瘤发病、死亡状况及其对期望寿命的影响
- Author:
Lu-lu REN
1
;
Yi-xuan MIN
1
;
Ya-ming YANG
1
;
Yue XIAO
1
;
Yan SUN
1
Author Information
1. Yixing Center for Disease Control and Prevention，Yixing，Jiangsu 214206，China
- Publication Type:Research Article
- Keywords:
malignant tumor;
incidence;
mortality;
life expectancy
- From:
Shanghai Journal of Preventive Medicine
2021;33(11):1012-1016
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the cancer incidence and mortality in Yixing City， Jiangsu Province in 2019. Methods:The cancer incidence and mortality in Yixing residents in 2019 were collected. Based on the data， the incidence and mortality rate， standardized incidence and mortality rate and age-specific incidence and mortality rate of cancer were calculated， and the incidence and death of major malignant tumors were also analyzed. Life table method was used to calculate life expectancy and life expectancy without cause of death. Results:The crude incidence of cancer in Yixing in 2019 was 308.61/105， the ASR China was 175.24/105， and the ASR World was 134.56/105. The crude mortality of cancer was 258.78/105， the ASR China was 125.19/105， and the ASR World was 93.01/105. The cancer incidence rate and mortality rate in males were higher than those in females. The top 5 cancers in incidence were lung， gastric， colorectal， thyroid， and esophageal cancers. The top 5 cancer deaths were lung， gastric， liver， esophageal， and colorectal cancers. In 2019， the life expectancy of Yixing residents was 82.53 years old， and the life expectancy without cause of cancer death was 86.15 years old. The biggest loss of life expectancy in the population was caused by lung cancer， followed by gastric cancer and liver cancer. Conclusion:The mortality rate of malignant tumors in Yixing is at a high level. Cancer prevention and treatment should be focused on lung cancer， thyroid cancer and malignant tumors of the digestive tract.
